LAG-3 (human): FC (human)
SIGMA/SRP8040 - recombinant, expressed in CHO cells, >99% (SDS-PAGE)
Synonym: FDC Protein; Lymphocyte activation gene-3; PC cell-derived growth factor
Product Type: Chemical
assay | >99% (SDS-PAGE) |
biological source | human |
color | clear |
concentration | ≥0.2 mg/mL |
form | liquid |
impurities | <0.1 EU/μg endotoxin, tested |
mol wt | ~80 kDa by SDS-PAGE |
packaging | pkg of 50 μg |
recombinant | expressed in CHO cells |
shipped in | wet ice |
storage temp. | −20°C |
UniProt accession no. | P18627 |
Biochem/physiol Actions: | LAG3 (lymphocyte activation gene 3) is a negative regulator of T-cell proliferation where it suppresses T-cell receptor (TCR)-mediated calcium fluxes and modulates the memory T-cell pool size. It is a CD4 (cluster of differentiation) homolog that functions as a ligand for MHC (major histocompatibility complex) II. Membrane expression of LAG3 modulates the suppressive function of Tregs (T-regulatory) both in vivo and in vitro. HIV-1 (human immunodeficiency virus) infection results in significant increase in LAG3 peripheral blood and lymph node expression, which is exhibited on both CD4+ and CD8+ T cells, and this is linked with disease progression. In melanoma, this protein is responsible for TLR (Toll-like receptor)-independent activation of plasmacytoid dendritic cells (pDCs) at tumor sites, which is partially implicated in driving an immune-suppressive environment. |
General description: | LAG3 (lymphocyte activation gene 3) is an inhibitory CD4 (cluster of differentiation)-related molecule, and is expressed by activated CD4+ and CD8+ T cells. |
Other Notes: | The sequence coding for the 4 extracellular Ig-like domains of human LAG-3 (D1-D4) is fused to the Fc portion of human IgG1. |
Physical form: | Solution in PBS. |
RIDADR | NONH for all modes of transport |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | >99% (SDS-PAGE) |
Storage Temp. | −20°C |
UNSPSC | 12352200 |